文献速递抗菌药物管理药物不良反应与药物警戒

重症成人艰难梭菌感染的预防

Prevention of Clostridium difficile Infection in Critically Ill Adults.
PubMed 文献 · Pharmacotherapy · 2019-01-01

本文综述重症成人艰难梭菌感染(CDI)的一级和二级预防证据。CDI预防需捆绑措施,包括强化卫生、诊断和抗菌药物管理,以及系统性抗生素治疗时继续口服万古霉素或非达霉素预防;减少抑酸剂、常规益生菌或早期粪菌移植的预防作用尚不明确。

要点

  • 强化卫生策略、诊断和抗菌药物管理是CDI预防的核心措施。
  • 系统性抗生素治疗时继续口服万古霉素或非达霉素预防已显示获益。
  • 减少抑酸剂、常规益生菌或早期粪菌移植的预防作用尚不明确。

核心结论

  • CDI预防需采用捆绑措施,包括减少可改变风险因素和减少艰难梭菌孢子传播。
  • 强化卫生、诊断和抗菌药物管理以及特定预防措施已显示获益。

研究设计与样本

  • 综述,总结重症成人CDI一级和二级预防证据。

主要发现

  • CDI预防为捆绑措施,难以量化单一元素影响。
  • 强化卫生策略、诊断和抗菌药物管理已显示获益。
  • 系统性抗生素治疗时继续口服万古霉素或非达霉素预防已显示获益。
  • 减少抑酸剂、常规益生菌或早期粪菌移植的预防作用尚不明确。

临床怎么用

  • 临床可实施强化卫生、诊断和抗菌药物管理以及特定预防措施。
  • 综述提供简洁实施路径供临床医生和政策制定者参考。

局限性

  • CDI预防为捆绑措施,难以量化单一元素影响。
  • 部分预防措施作用尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The incidence and severity of Clostridium difficile infection (CDI) remain high across intensive care units in the United States despite national efforts to decrease this escalating health care burden. Most published literature and guidelines address treatment rather than prevention, yet this approach may be too downstream to limit morbidity and mortality from the disease and its complications. Mechanisms to prevent CDI successfully include reducing modifiable risk factors and minimizing horizontal transmission of C. difficile spores between patients and the health care environment. Because CDI prevention is characterized by a bundled approach, it is difficult to quantify the individual impact of any one element; however, a number of patient- and facility-level strategies can be considered for CDI prevention. Robust hygiene strategies, diagnostic and antimicrobial stewardship, and particular prophylaxis maneuvers such as continuation of oral vancomycin or fidaxomicin in the setting of systemic antibiotics have all demonstrated benefit. The preventive roles of deprescribing acid suppressants, routine use of probiotics, or early fecal microbiota transplantation remain unclear. The focus of this review is to summarize the evidence related to primary and secondary CDI prevention in critically ill adults and provide a concise implementation pathway for clinicians and policymakers.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Leedahl DD, Personett HA, Nagpal A, et al. Prevention of Clostridium difficile Infection in Critically Ill Adults. Pharmacotherapy. 2019. PMID: 30506900. doi:10.1002/phar.2200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。